Live
Home·Deals·Healthcare·BioNTech SE acquires CureVac
BioNTech SE acquires CureVac (2026)
SEO URLwww.firestrike.ai/deals/curevac-biontech-se-acquisition-2026-2
acquisitionAnnounced · Jan 6, 2026HealthcareSource · Unverified ReportsArticle · Factual
CureVac
BioNTech SE
CureVac · BioNTech SE

BioNTech SE acquires CureVac

David Najork
David Najork · Founding Software Engineer
Published · Updated · 1 min read
ShareXLinkedInEmail
Deal value
Target
CureVac
CureVac
Tuebingen, Baden-Wuerttemberg
Acquirer
BioNTech SE
BioNTech SE
Full Acquisition
Status
Announced

BioNTech SE agreed to acquire CureVac. Reported deal value: Undisclosed. Status: Announced. Sector: Healthcare. Target headquarters context: Tuebingen, Baden-Wuerttemberg, Germany.

This page summarizes publicly available information about the transaction as of 2026-01-06. Figures and status may change as filings and press coverage update.

CureVac Final Chapter : BioNTech Acquisition Concludes mRNA Pioneer Independence 06.01. 20 26

Deal timeline

Announced
Jan 6, 2026 · ad-hoc-news.de
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in Healthcare. Figures and status may change as sources update.

Sources: ad-hoc-news.de · Primary article · FireStrike proprietary index